Showing posts with label Covid-19 vaccine. Show all posts
Showing posts with label Covid-19 vaccine. Show all posts

Saturday, April 10, 2021

FOURTH site halts J&J vaccinations within three days: Georgia clinic pauses shots over eight 'adverse reactions' after similar holds in Colorado, Iowa and North Carolina

Yet another clinic has paused vaccinations with Johnson & Johnson's shot after eight people suffered 'adverse reactions' at the Cummings, Georgia site.

Officials did not specify what types of reactions the eight people had to the shot, but said they were 'consistent with common reactions in adults being vaccinated with any vaccine,' and cited the number of cases as the trigger for the pause. 

However, the eight people who had reactions were among 425 people who got the J&J shot at that site and, ostensibly, did not have any noticeable reactions. 

The same thing has happened at clinics in three other states this week. 


J&J vaccinations have now resumed at a Colorado site that reported 11 people had had bad reactions to the one-dose vaccine and two were taken to hospitals.

India’s Covid cases hit another record as state with most infections locks down

India reported a record 145,384 new Covid-19 cases on Saturday and the highest number of deaths in more than five months, as it grapples with an overwhelming second-wave of infections that has forced the state of Maharashtra to impose a weekend lockdown.

Deaths rose by 794 to a total of 168,436, health ministry data showed.

India’s overall case load has swelled to 13.21 million, the third-highest globally, behind the United States and Brazil.

India has reported the most number of cases in the world in the past week, breaching the 100,000 mark for the first time on Monday and four times after that.

Wednesday, April 7, 2021

Oxford researchers pause trial of COVID-19 vaccine in children, teenagers

Researchers at Oxford University have paused a small pediatric clinical trial of the coronavirus vaccine it is developing with AstraZeneca.

In a statement, the university said it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA).

An Oxford spokesperson said there are no safety concerns concerning the pediatric research, but the trial is paused while they await "additional information" from MHRA, which is reviewing possible links between the vaccine and rare blood clots in adults.

The trial is testing the effectiveness of the vaccine in up to 300 children between the ages of 6 and 17.

"Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial," the university said.

AstraZeneca did not comment.

CDC distributes $3 billion for vaccine preparedness

The Centers for Disease Control and Prevention (CDC) is doling out more than $3.1 billion in federal funding under the last round of coronavirus relief legislation to help states and major cities administer vaccinations to their populations.

In press releases to local media, the CDC said it would distribute tens or hundreds of millions of dollars, based on a state's population, to prepare for mass vaccination campaigns set to begin this month. President Biden plans to announce today that he will make all adults over the age of 16 eligible to receive a vaccine by April 19, moving up a previously scheduled deadline of May 1.

CDC will send grants approved under the American Rescue Plan to 64 states, territories and major cities, ranging from $1.1 million to American Samoa and the Northern Marianas Islands to $357 million to the state of California, and more than $100 million each to Florida, New York, Ohio, Pennsylvania and Texas.

Monday, March 29, 2021

Pfizer-BioNTech Have Started Testing Their COVID-19 Vaccine in Children Under 12


Alejandra and Marisol Gerardo are nine years old but already making a little bit of history. The twin sisters are among the first young children to get vaccinated with a COVID-19 shot in Pfizer-BioNTech’s study of its vaccine in kids under age 12. 

Alejandraa and Marisol had their blood drawn in the morning on March 24, then got their first dose of the two-dose vaccine later that afternoon at Duke University Medical Center, one of four study sites in the U.S. for the trial.

Sunday, March 28, 2021

Pivoting to Childbirth at Home or in Freestanding Birth Centers1 in the US During COVID-19: Safety, Economics and Logistics


Birth-related decisions principally center on safety; giving birth during a pandemic brings safety challenges to a new level, especially when choosing the birth setting. Amid the COVID-19 crisis, the concurrent work furloughs, business failures, and mounting public and private debt have made prudent expenditures an inescapable second concern.

Motherhood on the brink in Yemen


“It was the morning of a normal working day before fighting escalated close to the hospital. I heard a mother screaming at the gate”, midwife Shrook Khalid Saeed told UNFPA, at the Al Shaab Hospital in the district of Crater, in Yemen. By the time she arrived at the entrance to the hospital, hostilities in the area had flared and a gunfight had broken out. 

“Bullets were coming from all the corners of the street”, she recounted. “When I arrived at the gate, I found the pregnant woman lying down and crying for help. I pulled her and rushed her inside a car. That is where all of it happened. In a few minutes, she had delivered a healthy baby boy.”

Pregnancy And Covid-19: How A Telehealth Company Is Combating Vaccination Hesitancy


For some companies—like those in telehealth—the Covid-19 crisis has brought opportunities as well as challenges. Telemedicine has been around since the late 1960s, but it took the coronavirus pandemic to make it a mainstay of healthcare delivery, especially for pregnant women. Healthcare providers have been able to maintain social distancing best practices and still provide services.

Shattering the infertility myth: What we know about Covid-19 vaccines and pregnancy


During trying times, myths and falsehoods sprout like mushrooms after rainfall. One of many that has emerged so far during the Covid-19 pandemic is that vaccines against the disease will cause infertility in women. It won’t. The likely origin of this myth is a letter sent to the European Medicines Agency (the equivalent of the U.S. Food and Drug Administration) by two European anti-vaccination propagandists. They erroneously claimed that the “vaccine contains a spike protein called syncytin-1 that is vital for the human placenta in women.”

More than 100K COVID-19 vaccines given in Virginia since Saturday as state reports 1,392 new cases


The Virginia Department of Health released their daily updated numbers involving COVID-19 cases within the state. According to their website, there are now 615,366 total cases, 481,351 of which are confirmed and 134,015 are probable. There are 10,198 total COVID-19 related deaths, with 8,553 being confirmed and 1,645 being probable. The case numbers are up by 1,392, and deaths are up by 20 since Saturday.

COVID-19: UK hits 30 million first vaccine doses - 57% of all adults


New government figures show 30,151,287 have had a first dose - around 57% of all UK adults.A total of 3,527,481 have now had two vaccine doses - 6% of the adult population. Ministers remain confident that all over-50s will have been offered a first dose by 15 April. The government aims to offer all adults a jab by the end of July.

Friday, March 26, 2021

Shattering the infertility myth: What we know about Covid-19 vaccines and pregnancy


During trying times, myths and falsehoods sprout like mushrooms after rainfall. One of many that has emerged so far during the Covid-19 pandemic is that vaccines against the disease will cause infertility in women.

COVID-19 vaccines are safe and effective in pregnancy, new study shows


The Moderna and Pfizer COVID-19 vaccines trigger strong immune responses in pregnant and breastfeeding women, equivalent to that of other women of reproductive age, preliminary research shows.

Pfizer-BioNtech COVID-19 Vaccine Can Now Be Stored at Higher Temperatures


Pfizer and BioNTech just announced they got the approval of European health authorities for their COVID-19 vaccine to be stored at higher temperatures.

Thursday, March 25, 2021

EU goes ‘better dead than red’ on Russian vaccine & China sanctions. Guess whose interests it really serves?


While the EU says it’s pursuing an autonomous foreign policy, its actions this month show that it’s perfectly fine being a pawn in America’s New Cold War.

Russian Aluminium delivers Sputnik V vaccine to Guinea


Russian Aluminium (RusAl), a leading global aluminium producer, has delivered to Guinea a consignment of the world's first registered vaccine against COVID-19 Sputnik V, as well as medical preparations and consumables for the diagnosis and treatment of COVID-19.

BREAKING: Sputnik V is the world’s most recognisable vaccine, a YouGov

Poll conducted in 9 countries comprising 1⁄4 of the world’s population finds, with over 74% of those surveyed having heard of the Russian vaccine.

Mystery remains about Sputnik vaccines seized in Mexico


MEXICO CITY -- Mexican prosecutors said Wednesday they remain unsure about whether the supposed Russian coronavirus vaccines seized in Mexico last week are real or fake.

Meet the Russian 'Information Warrior' Seeking To Discredit COVID-19 Vaccines


The Biden Administration issued an open threat on March 8 to several Russian media outlets. Over the last few months, the U.S. had been monitoring their campaign of “disinformation” about COVID-19 vaccines, and it now intended to push back “with every tool we have,” the White House said.

Thursday, March 18, 2021